A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo Pathway
Background/Aims: The roles and related mechanisms of RNA binding protein FUS (fused in sarcoma/translocated in liposarcoma) are unclear in numerous cancers, including hepatocellular carcinoma (HCC). Methods: Quantitative reverse transcription PCR (qRT-PCR), western blot, cell viability, transwell mi...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Cell Physiol Biochem Press GmbH & Co KG
2018-10-01
|
| Schriftenreihe: | Cellular Physiology and Biochemistry |
| Schlagworte: | |
| Online-Zugang: | https://www.karger.com/Article/FullText/494155 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|